| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.039 | 0.5 |